How mutations in bodily tissues affect ageing
Two new studies from Karolinska Institutet in Sweden have investigated how mutations that occur in muscles and blood vessels over time can affect ageing. The studies, which are published in Nature Aging, show that such mutations can reduce muscle strength and accelerate blood vessel ageing. The results can be of significance to the treatment of age-related diseases.

Somatic mutations are non-hereditary genetic changes in cells and occur during a lifetime as a result of environmental factors or through random errors when a cell copies its DNA before dividing. The mutations can give rise to cancer, but otherwise their effect has been disputed.
“We’ve discovered that mutations that accumulate in muscle cells and blood vessels can affect the tissue’s function and ability to regenerate – i.e. to replace damaged tissue with new healthy cells – an ability that also declines with age,” says principal investigator Maria Eriksson, professor at the Department of Medicine in Huddinge, Karolinska Institutet.
The same mutation as in progeria
In 2003, Professor Eriksson discovered the genetic cause of progeria, an inherited and extremely rare disease in children characterised by rapid ageing and cardiovascular complications. The child carries a mutation that leads to the formation of a pathogenic protein called progerin. Her research group has now been able to demonstrate the presence of the same mutation and protein in the blood vessels of some patients with chronic kidney disease.
“A somatic mutation has occurred in the patients’ vascular walls and we suspect that it’s related to the vascular damage that often accompanies kidney disease,” says the study’s first author Gwladys Revêchon, postdoc in Professor Eriksson’s group.
In complementary experiments in mice, the researchers discovered that cells that form progerin can propagate and cluster into groups of mutated cells that spread along the vascular walls, which can contribute to tissue damage and early vascular ageing.
The study combines basic and clinical research and was conducted in collaboration with Peter Stenvinkel, professor of nephrology at the Department of Clinical Science, Intervention and Technology at Karolinska Institutet and consultant at Karolinska University Hospital. He has established a large biobank of well-characterised material from patients, which has been crucial to the study.
“I’m very happy that we can now learn more about why people with kidney disease so easily become vascular compromised,” says Professor Stenvinkel.
Mutations affect muscle strength
In the second study, Professor Eriksson and her doctoral student Lara G. Merino and former postdoc Peter Vrtačnik used a mouse model to study how somatic mutations in muscles affect muscle strength. Such mutations accumulate during muscle regeneration, which is to say when muscles are rebuilt after having been damaged or strained.
An accumulation of somatic mutations in the muscles of mice led to impaired muscle regeneration, smaller muscle cells, lower muscle mass and reduced grip strength.
The results from both studies indicate that somatic mutations can reduce muscle strength and accelerate the ageing of the blood vessels.
“A better understanding of how somatic mutations affect the function of different tissues can help us develop new biomarkers and treatments for age-related diseases,” says Professor Eriksson. “Our findings also demonstrate the value of studying rare diseases since it can provide new approaches to more common conditions.”
The studies were primarily financed by grants from the Swedish Research Council, the Swedish Cancer Society, the European Research Council (ERC), the Center for Innovative Medicine (CIMED), the Loo and Hans Osterman Foundation for Medical Research and the Erik Rönnberg Award for Scientific Studies of Ageing and Age-related diseases. There are no reported conflicts of interest.
Publications
“Recurrent somatic mutation and progerin expression in early vascular aging of chronic kidney disease”, Gwladys Revêchon, Anna Witasp, Nikenza Viceconte, Hafdis T. Helgadottir, Piotr Machtel, Fabiana Stefani, Daniel Whisenant, Agustin Sola-Carvajal, Dagmara McGuinness, Nadia O. Abutaleb, Gonzalo Artiach, Emelie Wallén Arzt, Inga Soveri, Anne Babler, Susanne Ziegler, Rafael Kramann, Magnus Bäck, Anders Thorell, George A. Truskey, Lars Wennberg, Paul G. Shiels, Annika Wernerson, Peter Stenvinkel, Maria Eriksson, Nature Aging, online 10 June 2025, doi: 10.1038/s43587-025-00882-6.
“Induced somatic mutation accumulation during skeletal muscle regeneration reduces muscle strength”, Peter Vrtačnik, Lara G. Merino, Santhilal Subhash, Hafdis T Helgadottir, Matthieu Bardin, Fabiana Stefani, Depin Wang, Ping Chen, Irene Franco, Gwladys Revêchon, Maria Eriksson, Nature Aging, online 20 August 2025, doi: 10.1038/s43587-025-00941-y.
Kontakter
Maria ErikssonProfessor at the Department of Medicine, Huddinge, Karolinska Institutet
Tel:+46 70 827 89 69maria.eriksson.2@ki.sePress OfficeKarolinska Institutet
Tel:+46 (0)8 524 860 77pressinfo@ki.seki.se/pressroomBilder



About Karolinska Institutet
Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Följ Karolinska Institutet - English
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från Karolinska Institutet - English
POTS common in patients with long COVID3.10.2025 11:33:37 CEST | Press Release
A new study from Karolinska Institutet in Sweden shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those affected are middle-aged women. The study is published in the scientific journal Circulation: Arrhythmia and Electrophysiology.
Simple test can predict risk of severe liver disease29.9.2025 09:00:00 CEST | Press Release
A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can predict the risk of developing severe liver disease. The method may already start to be applied in primary care to enable the earlier detection of cirrhosis and cancer of the liver.
Press invitation: Announcement of the Nobel Prize in Physiology or Medicine 202523.9.2025 13:00:00 CEST | Press Invitation
The Nobel Prize in Physiology or Medicine 2025 will be announced on Monday October 6 at 11.30 am CEST (at the earliest).
New research confirms that neurons form in the adult brain3.7.2025 20:00:00 CEST | Pressmeddelande
A study in the journal Science presents compelling new evidence that neurons in the brain’s memory centre, the hippocampus, continue to form well into late adulthood. The research from Karolinska Institutet in Sweden provides answers to a fundamental and long-debated question about the human brain’s adaptability.
Gene therapy restored hearing in deaf patients2.7.2025 11:00:00 CEST | Pressmeddelande
Gene therapy can improve hearing in children and adults with congenital deafness or severe hearing impairment, a new study involving researchers at Karolinska Institutet reports. Hearing improved in all ten patients, and the treatment was well-tolerated. The study was conducted in collaboration with hospitals and universities in China and is published in the journal Nature Medicine.
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.
Besök vårt pressrum